Back to search
Prescribing, Off-Label
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prescribing, Off-Label trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prescribing, Off-Label trials you may qualify forThe purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genom…
This study evaluates the time spent on obtaining insurance approval and drugs, means of insurance coverage, out-of-pocket costs for patients, and the surgical o…
This study seeks to determine the feasibility, acceptability, and preliminary efficacy of an intervention consisting of off-label use of a medication with stron…
Many FDA-approved drugs are not available to patients with a particular cancer because there has been no successful clinical trial conducted for that drug again…
Off-label drug use, where a marketed drug is used outside its approved indication, may allow early access to new and promising treatments. However, its use can…
The purpose of this clinical trial is to evaluate the efficacy and safety of Doxecitin and Doxribtimine (dC+dT) in adult participants with thymidine kinase 2 (T…
CARTIZ is a prospective observational clinical registry of adults in Mexico receiving tirzepatide (a dual GLP-1/GIP receptor agonist) under an independent clini…
The primary objective of this study is to evaluate the safety and tolerability of the dietary supplement, nicotinamide mononucleotide (NMN), in individuals with…
The purpose of this registration is to list Managed Access Programs (MAPs) related to CTL019, Tisagenlecleucel